Navigation Links
Marken Expands Regulatory And Technical Excellence In Logistics
Date:1/30/2013

RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2013 /PRNewswire/ -- Marken today announced the expansion of its internal regulatory and technical expertise with the promotion of Dan Bell to Vice President.  The announcement follows an industry-led panel discussion hosted by Marken in Farmingdale, New York on January 15th.  The panel was convened to shed light on the growing complexity of clinical supply chain management.  Industry experts shared a wide range of perspectives relating to clinical trials risk, cost, resources and security.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Rafik Bishara , Ph.D., current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association (PDA), said: "There is a very clear shift in how we should view 'cold chain' logistics, especially with the growth of biologically derived drugs and vaccines.  Supplier's Quality Systems will need to be expanded to include increased tracking for chain of custody assurance, more reliable data monitoring and compliance with changing customs requirements in developing countries. This shift will go far beyond our current understanding and application of Good Distribution Practices."  The panel was moderated by Pfizer's Bruce Guenter , who said: "Our industry will certainly demand more reliable monitoring of data and will need to ensure compliance with the changing regulations.  It is vital to our industry that we continue to coordinate collaborative exchanges like this to ensure that we are ready, prepared, and ahead of the curve." 

Marken has long been known for its high quality, compliant and reliable service to the pharmaceutical industry.  A new unit has been formed, expanding on Marken's already strong legacy of compliance, and has promoted Dan Bell to a newly created position of Vice President, Regulatory Compliance and Technical Affairs. Wes Wheeler , Marken's CEO, said: "Dan has been instrumental to Marken's growth and has developed strong relationships with some of the industry's most demanding clients.  He is recognized in the industry as a frequent speaker on important issues in cold chain logistics and regulatory challenges.  He is passionate about advancing new techniques, finding solutions and expanding the knowledge base in clinical logistics."

Mr. Bell is also a licensed customs broker and a certified customs specialist in the United States.  He will join Marken's Executive Committee and work with Marken to set objectives for 2013 and beyond.

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Announces Global Advisory Board
4. Marken Launches New Global Regulatory Consultation Services
5. Marken Enhances Branch Operations
6. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
7. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
8. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
9. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
10. S1 Biopharma Expands Focus to Include Male Sexual Health
11. PRA Expands Operations in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/4/2017)...  According to the Centers for Disease Control and Prevention (CDC), ... Urgent Care is helping communities across Massachusetts , ... offering no-cost* flu shots through the end of the month. ... regulations. ... a flu shot is by the end of October, according to the ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra ... care advancements to physician colleagues, skilled nursing facility medical directors and other clinicians ... Waters of Wound Care." , "At many of these conferences we get to ...
Breaking Medicine News(10 mins):